Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/2007
05/23/2007CN1965890A Pain-relieving bleeding-stopping powder of lamiophlomis rotata (Benth,) kudo
05/23/2007CN1965884A Chinese medicine for treating traumatic bleeding and swelling pain cause by skin sore and carbuncle
05/23/2007CN1965822A Sustained release formulation of bilobalide-B and preparation process thereof
05/23/2007CN1965818A Prescription for preparing high-quality tranexamic acid injection and preparation process thereof
05/23/2007CN1965697A Health beverage capable of nourishing blood
05/23/2007CN1965670A Beverage prepared by lotus leaf and cordate houttuynia
05/23/2007CN1317033C Blood nourishing body building composition and its production method
05/23/2007CN1316992C Medicine for treating heart brain embulus disease and its preparation method
05/23/2007CN1316989C Capsule for treating disease of nutrition deficiency and its preparing process
05/22/2007US7220829 Cytokine binding domain of cytokine receptors
05/22/2007US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties
05/22/2007US7220758 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
05/22/2007US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example
05/22/2007US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening
05/22/2007US7220569 Nucleic acids encoding factor X analogues having a modified protease cleavage site
05/22/2007CA2378852C Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives
05/22/2007CA2241466C Pharmaceutical composition containing angiotensin ii antagonist
05/22/2007CA2111645C Fibrinogen fragment e peptides and antibodies thereto
05/18/2007WO2007055183A1 Benzene derivative or salt thereof
05/18/2007WO2007053952A1 Platelet factor-4 (pf-4) analogs and their use
05/18/2007WO2007033140A3 Prok2 antagonists and methods of use
05/18/2007WO2007023154A3 Iron (iii) complex compounds for treating iron deficiency in patients with chronic inflammatory intestinal diseases
05/18/2007WO2007022784A3 Liquid factor vii composition
05/18/2007WO2006114105A3 Use of modified factor vii for treating bleeding
05/18/2007CA2628848A1 Compositions and methods for treating thrombocytopenia
05/17/2007US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors
05/17/2007US20070112029 Piperidine compound and process for preparing the same
05/17/2007US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
05/17/2007US20070111266 Antibodies to murine zcytor17 ligand
05/17/2007US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
05/16/2007EP1785418A1 Pyrazole derivative
05/16/2007EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
05/16/2007EP1784190A1 Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
05/16/2007EP1372700B1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
05/16/2007EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
05/16/2007CN1964990A Antibodies specific for glycoprotein VI and methods of producing these antibodies
05/16/2007CN1964729A Composition for prevention and treatment of urinary incontinence
05/16/2007CN1964727A Agent for removing factor causing circulatory dysfunction
05/16/2007CN1964721A A medical solution, a method for producing said medical solution and use thereof
05/16/2007CN1964703A Immediate release pharmaceutical tablets with height greater than width
05/16/2007CN1962862A Method for high-density fermentation production of recombinant earthworm fibrinolysin PI239 in yeast system and engineering bacterium therefor
05/16/2007CN1962641A Metalloproteinase inhibitors
05/16/2007CN1962640A Synthesis of n2 - (substituted arylmethyl) -3- (substituted phenyl) indazoles as novel anti-angiogenic agents
05/16/2007CN1962596A Ketone compounds and compositions for cholesterol management and related uses
05/16/2007CN1961952A Medicament for promoting diuresis and diminishing inflammation and preparation process thereof
05/16/2007CN1961951A Chinese medicinal formulation for treating hydrocephalus
05/16/2007CN1961912A Chinese medicinal composition containing pain-easing bleeding-stopping functions
05/16/2007CN1961892A Dalbergia wood and beta-cyclodextrin inclusion compound, formulation thereof and preparation method thereof
05/16/2007CN1961745A Application of fructus cannabis protein in preparation of health food for relieving nutritional anemia
05/16/2007CN1315870C Peptide and compounds that bind to receptor
05/16/2007CN1315857C Preparation of Chinese medicine clinopodium polycephalum saponin
05/16/2007CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
05/16/2007CN1315835C Polycyclic guanine phosphodiesterase v inhibitors
05/16/2007CN1315833C Azaindole kinase inhibitors
05/16/2007CN1315803C Aminopyridyl-substituted phenyl acetamides as protease inhibitors
05/16/2007CN1315489C New use of fleahane preparation for teating acute respiratory distress syndrome
05/16/2007CN1315472C Motherwort dropping pill and its preparing method
05/15/2007US7217832 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
05/15/2007US7217719 1,3,8-Triaza-spiro[4.5]decan-2-one compounds, e.g., (4S)/(4R)-4-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-8-methyl-1,3,8-triaza-spiro [4.5]decan-2-one; treating schizophrenia, psychosis, migraine, hypertension, thrombosis, vasospasm, depression, anxiety, sleep and eating disorders
05/15/2007US7217701 Intracellular calcium concentration increase inhibitors
05/10/2007WO2007052841A1 Platelet aggregation inhibitor composition
05/10/2007WO2007052808A1 Hydrazide compound and thrombopoietin receptor activator
05/10/2007WO2007051926A1 Cytotoxic antibodies targeting antibodies inhibiting factor viii
05/10/2007WO2007051532A1 Phenylenebisoxazolidine derivatives and their use as anticoagulants
05/10/2007WO2007022321A3 Substituted indoles and use thereof
05/10/2007US20070106076 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles
05/10/2007US20070105958 Compounds for the treatment of metabolic disorders
05/10/2007US20070105949 Intermediates for the preparation of lipoxin A4 analogs
05/10/2007US20070105933 Amino alcohol compounds
05/10/2007US20070105894 Combination of at least two compounds selected from an AT1-receptorantagonist or an ACE inhibitor or a HMG-Co-A reductase inhibitor
05/10/2007US20070105889 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for therapy of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea
05/10/2007US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors
05/10/2007US20070105829 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
05/10/2007US20070105753 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors
05/10/2007CA2638166A1 Cytotoxic antibodies targeting antibodies inhibiting factor viii
05/10/2007CA2627759A1 Phenylenebisoxazolidine derivatives and their use as anticoagulants
05/10/2007CA2625106A1 Platelet aggregation inhibitor composition
05/09/2007EP1783222A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity.
05/09/2007EP1783115A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use
05/09/2007EP1781782A1 Modified vitamin k dependent polypeptides
05/09/2007EP1781645A1 Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
05/09/2007EP1781281A1 Compositions for urinary dysfunction and edema containing decursin and/or decursinol angelate, or angelica extract containing decursin and /or decursinol angelate
05/09/2007EP1682530B1 Pyrrole substituted indoles as inhibitors of pai-1
05/09/2007EP1365788B1 Thrombomodulin analogs for use in recovery of spinal cord injury
05/09/2007EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
05/09/2007EP1183245B1 Selective npy (y5) antagonists
05/09/2007CN1960745A Combination dosing regimen for erythropoietin
05/09/2007CN1960706A Superloaded liposomes for drug delivery
05/09/2007CN1958790A New thrombin in snake poison categories of hundred-paced pit viper, and styptic activity
05/09/2007CN1958055A Chinese traditional medicine for treating increased urinary frequency, enuresis, and preparation method
05/09/2007CN1958005A Combination of Chinese traditional medicine, preparation method, and quality control method
05/09/2007CN1957998A Animal use compound medicament with effects of removing toxic heat, removing heat from the blood to stop bleeding, and preparation method
05/09/2007CN1314677C Acetyl salicyl puerarin derivatives and preparation method and use thereof
05/08/2007US7214688 Compounds
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
05/08/2007US7214661 Methods of therapy with thrombin derived peptides
05/08/2007US7214495 Screening method
05/08/2007CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines
05/08/2007CA2207120C Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation
05/03/2007WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient